| scholarly article | Q13442814 |
| P2093 | author name string | Hideharu Funatsu | |
| Hidetaka Noma | |||
| Tatsuya Mimura | |||
| Katsunori Shimada | |||
| Shuichiro Eguchi | |||
| P2860 | cites work | Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion | Q36786468 |
| Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion | Q39519340 | ||
| Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retinal vein occlusion | Q39906047 | ||
| Pigment epithelium-derived factor and vascular endothelial growth factor in branch retinal vein occlusion with macular edema | Q42935588 | ||
| The natural course of retinal branch vein obstruction. | Q43716633 | ||
| Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular edema associated with branch retinal vein occlusion: retinal tomography and visual outcome | Q43835845 | ||
| Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. | Q44432980 | ||
| The natural course of temporal retinal branch vein occlusion. | Q45182643 | ||
| Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. | Q46640228 | ||
| Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion | Q46678876 | ||
| VEGF increases retinal vascular ICAM-1 expression in vivo. | Q48171299 | ||
| Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. | Q51938226 | ||
| Quantitative assessment of macular edema with retinal vein occlusion. | Q52235897 | ||
| Pathology of cystoid macular edema. | Q52505011 | ||
| Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta | Q61053091 | ||
| Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group | Q70379149 | ||
| Pathology of human cystoid macular edema | Q70574403 | ||
| Macular edema and cystoid macular edema | Q70964368 | ||
| Tomographic assessment of vitreous surgery for diabetic macular edema | Q73676017 | ||
| 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee | Q74586325 | ||
| Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis | Q79782464 | ||
| Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion | Q79790355 | ||
| Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis | Q24684263 | ||
| Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition | Q28343572 | ||
| Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor | Q28567494 | ||
| Grid laser treatment in macular branch retinal vein occlusion | Q30835658 | ||
| Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells | Q30990451 | ||
| Perimetric sensitivity and retinal thickness in eyes with macular edema resulting from branch retinal vein occlusion | Q31857731 | ||
| Changes of vascular endothelial growth factor after vitrectomy for macular edema secondary to retinal vein occlusion. | Q33383066 | ||
| Visual acuity and foveal thickness after vitrectomy for macular edema associated with branch retinal vein occlusion: a case series | Q33568145 | ||
| Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site | Q33696019 | ||
| Cellular mechanisms of blood-retinal barrier dysfunction in macular edema | Q33969496 | ||
| The molecular structure and function of the inner blood-retinal barrier. Penn State Retina Research Group | Q33969502 | ||
| Increase of aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case control study | Q34149323 | ||
| Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate | Q34409210 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 223-229 | |
| P577 | publication date | 2011-02-15 | |
| P1433 | published in | Clinical Ophthalmology | Q5133782 |
| P1476 | title | Visual prognosis and vitreous molecules after vitrectomy for macular edema with branch retinal vein occlusion | |
| P478 | volume | 5 |
| Q54296966 | Effects of avastin on expression of AQP4 in Müller cells under hypoxia. |
| Q44694326 | Influence of retinal ischemia on macular function after pars plana vitrectomy for macular edema with branch retinal vein occlusion |
| Q33771458 | Intraocular soluble intracellular adhesion molecule-1 correlates with subretinal fluid height of diabetic macular edema |
| Q38848800 | New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein Occlusion |
| Q35168707 | Outcomes of microincision vitrectomy surgery with internal limiting membrane peeling for macular edema secondary to branch retinal vein occlusion |
Search more.